Sun Pharmaceutical (SUNPHARMA) — Board Meeting

Sun Pharmaceutical Industries announced the appointment of Kirti Ganorkar as Managing Director effective September 1, 2025, with a five-year term pending shareholder approval at the upcoming AGM. Dilip Shanghvi will transition to Executive Chairman, focusing on specialty portfolio growth and strategic oversight. The board also noted Abhay Gandhi's departure and Rick Ascroft's appointment as North America CEO, reporting to Aalok Shanghvi.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this board meeting affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 13 June 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 13 June 2025

INDHOTEL The Indian Hotels Company Limited Annual Report INDUSINDBK IndusInd Bank Limited Announcement VEDL Vedanta Limited Corporate Action VBL Varun Beverages Limited Corporate Action INDHOTEL The Indian Hotels Company Limited Annual Report ITC ITC Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.